You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Alnylam cites charge for earnings loss

Alnylam cited a one-time charge for its net loss.

istockphoto.com

Alnylam cited a one-time charge for its net loss.

Continue reading below

Alnylam Pharmaceuticals Inc. reported a fourth-quarter net loss of $63.2 million, or $1.20 per share, compared with a loss of $14.3 million, or 33 cents, in the same period last year. For the year, the net loss was $106 million, or $2.11 per share, compared with a loss of $57.6 million, or $1.36, for the prior year. The Cambridge biotech cited a one-time charge of $65 million related to the restructuring of its licensing agreement with Tekmira Pharmaceuticals Corp. for the loss.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.